Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Andrew Meds vs Renlo Health

Andrew Meds
Graded #185

Lower grade

vs+12.6
Renlo Health
Graded #41

Higher grade

The verdict

Renlo Health takes it — 79.7/100 to 67.1/100.

Renlo Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. One of the few programs whose headline is the actual monthly rate, with the prescribing physician and the dispensing pharmacy both named.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRenlo Health +30
54
84
Dose & formulationRenlo Health +8
64
72
Clinical oversightRenlo Health +7
81
88
Labs & monitoringRenlo Health +5
53
58
FulfillmentAndrew Meds +4
94
90
Contract termsRenlo Health +23
67
90
Andrew Meds · left barRenlo Health · right bar

The numbers

MetricAndrew MedsRenlo Health
WeighScore67.1/10079.7/100
GradeCC+
Scorecard rank#185#41
Semaglutide$199/mo (product page; two live intake funnels price semaglutide differently)$199/mo, billed monthly at every dose
Tirzepatide$299/mo (product page; neither GLP-1 funnel offered tirzepatide when walked)$269/mo, billed monthly at every dose
CoverageAll 50 states plus Washington, D.C.Not publicly listed
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Andrew Meds

Graded #185 · C

Strengths

  • States its compounding class in plain language on the product pages — a 503(A) pharmacy or a 503(B) outsourcing facility — which most of the field leaves unstated
  • Names the prescribing practice in the footer of every page
  • Prices sit on the product pages before any intake, and free expedited shipping is stated rather than added at checkout
  • Serves all 50 states and the District of Columbia, stated in the footer without a hedge

Where it loses points

  • Three live semaglutide figures the site never reconciles: $199 a month on the product page, $99 a month in the microdosing funnel, and $149 for a four-week supply in the second funnel
  • Every Get Started button on the compounded semaglutide page lands on a microdosing intake, which is a different program from the one the page describes
  • Both GLP-1 intakes ended offering only semaglutide, so whether tirzepatide can be bought through the current funnels is unclear
  • The funnel promises a 100% success guarantee and a money-back weight-loss guarantee while the Terms say refunds are not offered for partially used subscription periods
  • The pharmacy class is stated but no pharmacy is named, and no individual clinician or NPI appears anywhere
  • An oral tirzepatide product is advertised on both GLP-1 pages and every link to it resolves to a page that does not list it
Renlo Health

Graded #41 · C+

Strengths

  • The headline is the real month-to-month rate — no prepay division and no commitment behind an asterisk
  • A genuine all-in line: medication, injection supplies, provider evaluation, ongoing care, expedited shipping and unlimited care-team messaging, with no membership or consultation fees
  • Names the prescribing physician, Dr. Sean Arora, MD, and the dispensing pharmacy, VialsRX
  • Same price at every dose with a price-lock badge
  • A four-month money-back guarantee, and cancel anytime with no fee

Where it loses points

  • A struck-through $399 sits beside the price with no published basis — Renlo never says what it was, when it applied or to whom
  • That strikethrough comes from a stylesheet rule rather than a struck-out element, so a markup-level check would report the page clean
  • A comparison table headed "Most GLP-1 providers" quotes $270, $365 and $445 by dose while naming no provider and citing no source
  • A site-wide $50 code means the advertised figure is not the first amount charged
  • No lab protocol is published, and there is no oral or brand route

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard